Maia Nestor-Martin
Maia Nestor-Martin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bernard Malissen
Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université, INSERM, CNRS, Marseille, France
1 shared publication - Daniel Metzger
Université de Strasbourg, CNRS, Inserm, IGBMC UMR 7104-UMR-S 1258, F-67400 Illkirch, France
1 shared publication - Darya Yanushko
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
1 shared publication - Despoina Pervizou
Centre d’Immunologie de Marseille-Luminy
1 shared publication Dunja Capitan-Sobrino
Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), Inserm UMR1291, CNRS UMR5051, University of Toulouse, Centre Hospitalier Universitaire (CHU) de Toulouse - Purpan
1 shared publication- Frédéric Fiore
Centre d’Immunophénomique, Aix Marseille Université, INSERM, CNRS, 13288 Marseille, France
1 shared publication
Latest Publications
- Open Access
- 26 September 2025
- Published by Taylor & Francis in OncoImmunology
- Vol. 14 (1) , 2562220
Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression
The immune landscape of healthy prostate and its alterations during prostate cancer (PCa) progression remain poorly characterized. Using scRNA-sequencing and multiparametric flow-cytometry analysis, we comprehensively characterized immune cells in wild-type and PTEN(i)pe-/- mouse prostates, a model that closely recapitulates human PCa. PCa in PTEN(i)pe-/- is marked by the recruitment of tumor-associated neutrophils (TANs), which represent the dominant immune cell population and resolved into eight distinct states, Trem2+ tumor-associated-macrophages (TAMs), and exhausted CD8+ T cells. Trem2+ TAMs differ from the three main resident macrophage populations in the healthy prostate, exhibiting a strong metabolic and immunosuppressive signature, likely driven by the MIF/HIF1A-signaling axis. This study provides the first detailed characterization of immune cells in the healthy mouse prostate and reveals changes in the immune landscape associated with prostate cancer progression.
- 26 September 2025
- Published by Taylor & Francis in OncoImmunology
- Vol. 14 (1) , 2562220
Open AccessCharacterization of the immune landscape in healthy mouse prostate and during prostate cancer progression
The immune landscape of healthy prostate and its alterations during prostate cancer (PCa) progression remain poorly characterized. Using scRNA-sequencing and multiparametric flow-cytometry analysis, we comprehensively characterized immune cells in wild-type and PTEN(i)pe-/- mouse prostates, a model that closely recapitulates human PCa. PCa in PTEN(i)pe-/- is marked by the recruitment of tumor-associated neutrophils (TANs), which represent the dominant immune cell population and resolved into eight distinct states, Trem2+ tumor-associated-macrophages (TAMs), and exhausted CD8+ T cells. Trem2+ TAMs differ from the three main resident macrophage populations in the healthy prostate, exhibiting a strong metabolic and immunosuppressive signature, likely driven by the MIF/HIF1A-signaling axis. This study provides the first detailed characterization of immune cells in the healthy mouse prostate and reveals changes in the immune landscape associated with prostate cancer progression.
- Open Access
- 12 September 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (37)
Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function
Innate B-1 cells constitute a self-maintained layer of defense for early detection of bacteria, clearance of apoptotic cell debris, and removal of autoantigens driving autoimmunity. B-1 cells are originated from fetal tissues, but, as opposed to B-2 cells, the molecular mechanisms behind their development and homeostatic maintenance remain largely unknown. Here, we demonstrate that posttranscriptional regulation by the RNA binding protein HuR is essential for the homeostatic self-replenishment of innate B-1a cells, the expansion of B-1 cell clones targeting self-antigens, and the production of natural autoantibodies. HuR KO B-1 cells fail to express the high levels of surface B-cell receptor (BCR), TACI, and BAFFR required for tonic signaling and cell survival. At the molecular level, HuR promotes the translation of messenger RNAs encoding the IgM heavy chain and modules, in a direct or indirect manner, the expression of TACI and BAFFR. In summary, we reveal the need for posttranscriptional regulation in BCR expression, tonic signaling, and homeostatic maintenance of functional innate B-1 cells.
- 12 September 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (37)
Open AccessPosttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function
Innate B-1 cells constitute a self-maintained layer of defense for early detection of bacteria, clearance of apoptotic cell debris, and removal of autoantigens driving autoimmunity. B-1 cells are originated from fetal tissues, but, as opposed to B-2 cells, the molecular mechanisms behind their development and homeostatic maintenance remain largely unknown. Here, we demonstrate that posttranscriptional regulation by the RNA binding protein HuR is essential for the homeostatic self-replenishment of innate B-1a cells, the expansion of B-1 cell clones targeting self-antigens, and the production of natural autoantibodies. HuR KO B-1 cells fail to express the high levels of surface B-cell receptor (BCR), TACI, and BAFFR required for tonic signaling and cell survival. At the molecular level, HuR promotes the translation of messenger RNAs encoding the IgM heavy chain and modules, in a direct or indirect manner, the expression of TACI and BAFFR. In summary, we reveal the need for posttranscriptional regulation in BCR expression, tonic signaling, and homeostatic maintenance of functional innate B-1 cells.